MENU
+Compare
GSK
Stock ticker: NYSE
AS OF
Apr 3, 01:14 PM (EDT)
Price
$38.77
Change
+$1.12 (+2.98%)
Capitalization
88.13B

GSK GSK plc Forecast, Technical & Fundamental Analysis

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales... Show more

GSK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for GSK with price predictions
Apr 02, 2025

GSK in +1.12% Uptrend, rising for three consecutive days on March 28, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where GSK advanced for three days, in of 325 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Aroon Indicator entered an Uptrend today. In of 221 cases where GSK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for GSK moved out of overbought territory on March 19, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on March 21, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on GSK as a result. In of 73 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for GSK turned negative on March 19, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GSK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

GSK broke above its upper Bollinger Band on March 07, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.144) is normal, around the industry mean (5.632). P/E Ratio (14.012) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (1.126) is also within normal values, averaging (3.004). Dividend Yield (0.035) settles around the average of (0.161) among similar stocks. P/S Ratio (2.277) is also within normal values, averaging (3.643).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GSK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GSK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock better than average.

View a ticker or compare two or three
GSK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

GSK is expected to report earnings to rise 189.61% to 66 cents per share on July 27

GSK plc GSK Stock Earnings Reports
Q2'22
Est.
$0.67
Q4'24
Missed
by $0.26
Q3'24
Beat
by $0.14
Q2'24
Beat
by $0.13
Q1'24
Beat
by $0.16
The last earnings report on February 05 showed earnings per share of 23 cents, missing the estimate of 49 cents. With 1.58M shares outstanding, the current market capitalization sits at 88.13B.
A.I.Advisor
published Dividends

GSK is expected to pay dividends on April 10, 2025

GSK plc GSK Stock Dividends
A dividend of $0.40 per share will be paid with a record date of April 10, 2025, and an ex-dividend date of February 21, 2025. The last dividend of $0.39 was paid on January 09. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of vaccines and other pharmaceutical products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
980 Great West Road
Phone
+44 2080475000
Employees
70212
Web
https://www.gsk.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MHLD0.610.04
+6.10%
Maiden Holdings Ltd
LLYVK71.541.51
+2.16%
Liberty Media Corp
PUK21.840.27
+1.25%
Prudential PLC
ULCC4.32N/A
N/A
Frontier Group Holdings
FTFT0.14-0.02
-11.11%
Future FinTech Group

GSK and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GSK has been loosely correlated with NVS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if GSK jumps, then NVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GSK
1D Price
Change %
GSK100%
-0.61%
NVS - GSK
49%
Loosely correlated
+1.06%
PFE - GSK
48%
Loosely correlated
+0.65%
SNY - GSK
40%
Loosely correlated
-0.72%
JNJ - GSK
39%
Loosely correlated
+1.38%
AZN - GSK
39%
Loosely correlated
-0.52%
More